News & Announcements
-
Winter Break - IRB Closure
In alignment with the University’s announcement and intent of the Winter Break Administrative Leave to allow time off to rest and relax, University of Utah IRB will be fully closed from December 24, 2020 through January 3, 2021, reopening on Monday, January 4, 2021.
-
ORIC Annual Report
The Office of Research Integrity and Compliance is proud to release the 2019-2020 ORIC Annual Report. In here, you’ll find information on new ORIC updates, department highlights, new resources and training, and a letter from Dr. Erin Rothwell, Associate Vice President for Research.
-
Operations Update
Our level of transmission is currently at “HIGH”. The new transmission index has not changed allowable research activities on campus. We are still currently under “Limited Research Activities Status”.
-
IRB & Research Preparations for COVID-19
The IRB is heeding current guidelines from University leaders in response to the COVID-19 outbreak. This announcement is to provide the research community with information regarding the review and conduct of human subject research during this time.
Events
-
Jan 28
Thursday
9am - 10amAdvanced Consideration of the Criteria for IRB Approval of Research
Zoom
-
Feb 01
Monday
REd Online: Advanced Consideration of the Criteria for IRB Approval of Research
Virtual
-
Feb 01
Monday
REd Online: Multi-Center Research Using a Single Institutional Review Board (SIRB)
Virtual
-
Feb 01
Monday
REd Online: Understanding IRB Applications in ERICA: New Studies, Amendments and Continuing Review
Virtual
-
Mar 01
Monday
REd Online: Advanced Consideration of the Criteria for IRB Approval of Research
Virtual
-
Mar 01
Monday
REd Online: Multi-Center Research Using a Single Institutional Review Board (SIRB)
Virtual
Human Research protection resources
The University of Utah is committed to excellence, innovation, and diversity in conducting transformative, high-quality research.
Office of Research Integrity & Compliance
Advancing research integrity and compliance through developing, demonstrating, and disseminating innovative processes, tools and outreach that improve scientific outcomes, transparency and accountability through the translational research continuum.
Human Research Protection Program
An institutional-wide program coordinated by the University of Utah’s Office of Research Integrity and Compliance (ORIC), and is composed of the executive officers, research review committees, and other entities that are responsible for protecting the rights and welfare of participants in research conducted or reviewed at the University of Utah.
- Office of Research Education (REd)
- Conflict of Interest (CoI)
- Institutional Biosafety Committee (IBC)
- Resource for Genetic & Epidemiologic Research (RGE)
- Research Participant Advocate (RPA)
- Study Locator
Protects the health and safety of the University community and its environment.
PARTNERS FOR INNOVATION, VENTURES, OUTREACH & TECHNOLOGY (PIVOT)
PIVOT (formerly TVC) serves as a catalyst for the regional ecosystem, responsible for all aspects of invention management, patent prosecution, licensing, startup formation and support, equity management and early-stage funding.
HCI Protocol Review & Monitoring Committee
If your study involves cancer patients, you will be directed in ERICA to submit your project to the PRMC at Huntsman Cancer Institute for review and approval.
Center for Clinical & Translational Science
The center serves as an academic home for clinical and translational research, developing innovative health services for the community and health researchers, and training a new generation of clinical and translational investigators.
The IRB adheres to the IRB responsibilities and requirements outlined in 38 CFR 16 and the VHA Directives when reviewing and making determinations for research conducted at the VA.
OFFICE OF RESEARCH INFORMATION SYSTEMS (ORIS)
ORIS manages the Information Systems of the Office of Research Integrity & Compliance
Contact ORIS at oris@utah.edu.
Office for Human Research Protections
Provides leadership in the protection of the rights, welfare, and wellbeing of human subjects involved in research conducted or supported by the U.S. Department of Health and Human Services (HHS).
Food & Drug Administration (FDA)
Responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
SMART IRB is a platform designed to ease common challenges associated with initiating multisite research and to provide a roadmap for institutions to implement the NIH Single IRB Review policy.
IREx is a freely available, web-based portal supporting
single IRB review documentation and coordination for multi-center clinical trials.
A collaborative national network that focuses on operational innovation, excellence and collaboration and will leverage the expertise and resources of the CTSA Program.
Trial Innovation Centers (TIC) are charged with coordinating and providing innovative, high quality operational support for TIN clinical trials.